EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid

Olga V Belyaeva, Alla V Klyuyeva iD, Ansh Vyas iD, Wilhelm K Berger iD, Laszlo Halasz, Jianshi Yu, Venkatram R Atigadda, Aja Slay, Kelli R Goggans iD, Matthew B Renfrow, Maureen A Kane, Laszlo Nagy und 1 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Olga V Belyaeva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of…. Hauptthemen laut MEDLINE: Furylfuramide, Tretinoin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rexinoids are agonists of nuclear rexinoid X receptors (RXR) that heterodimerize with other nuclear receptors to regulate gene transcription. A number of selective RXR agonists have been developed for clinical use but their application has been hampered by the unwanted side effects associated with the use of rexinoids and a limited understanding of their mechanisms of action across different cell types. Our previous studies showed that treatment of organotypic human epidermis with the low toxicity UAB30 and UAB110 rexinoids resulted in increased steady-state levels of all- trans -retinoic acid (ATRA), the obligatory ligand of the RXR-RAR heterodimers. Here, we investigated the molecular mechanism underlying the increase in ATRA levels using a dominant negative RXRα that lacks the activation function 2 (AF-2) domain. The results demonstrated that overexpression of dnRXRα in human organotypic epidermis markedly reduced signaling by resident ATRA, suggesting the existence of endogenous RXR ligand, diminished the biological effects of UAB30 and UAB110 on epidermis morphology and gene expression, and nearly abolished the rexinoid-induced increase in ATRA levels. Global transcriptome analysis of dnRXRα-rafts in comparison to empty vector-transduced rafts showed that over 95% of the differentially expressed genes in rexinoid-treated rafts constitute direct or indirect ATRA-regulated genes. Thus, the biological effects of UAB30 and UAB110 are mediated through the AF-2 domain of RXRα with minimal side effects in human epidermis. As ATRA levels are known to be reduced in certain epithelial pathologies, treatment with UAB30 and UAB110 may represent a promising therapy for normalizing the endogenous ATRA concentration and signaling in epithelial tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurylfuramideTretinoinHumansRetinoid X ReceptorsLigandsEpidermisReceptors, Cytoplasmic and Nuclear

Substanzen

Retinoid X ReceptorsLigandsFurylfuramideTretinoinReceptors, Cytoplasmic and Nuclear

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Departments of Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States of A…
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, United States of America.
  • Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.

ORCID-Profile: Alla V Klyuyeva, Ansh Vyas, Wilhelm K Berger, Kelli R Goggans, Natalia Y Kedishvili

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIAMS NIH HHS
  • UAB O’Neil Comprehensive Cancer Center
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • University of Maryland, School of Pharmacy

Zitieren

APA

Belyaeva, O. V., Klyuyeva, A. V., Vyas, A., Berger, W. K., Halasz, L., Yu, J., Atigadda, V. R., Slay, A., Goggans, K. R., Renfrow, M. B., Kane, M. A., Nagy, L., & Kedishvili, N. Y. (2024). The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid. PLOS ONE. https://doi.org/10.1371/journal.pone.0301447

Vancouver

Belyaeva OV, Klyuyeva AV, Vyas A, Berger WK, Halasz L, Yu J, et al. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid. PLOS ONE. 2024. doi:10.1371/journal.pone.0301447

BibTeX
@article{Belyaeva2024,
  author = {Belyaeva, Olga V and Klyuyeva, Alla V and Vyas, Ansh and Berger, Wilhelm K and Halasz, Laszlo and Yu, Jianshi and Atigadda, Venkatram R and Slay, Aja and Goggans, Kelli R and Renfrow, Matthew B and Kane, Maureen A and Nagy, Laszlo and Kedishvili, Natalia Y},
  title = {The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301447}
}
Kostenlos starten →